sales@angenesci.com
Login | Register
logo
Structures Search
Home Other Building Blocks CALCIUM D-(+)-4-(2,4-DIHYDROXY-3,3-DIMETHYLBUTYLAMIDO)BUTYRATE HEMIHYDRATE

CALCIUM D-(+)-4-(2,4-DIHYDROXY-3,3-DIMETHYLBUTYLAMIDO)BUTYRATE HEMIHYDRATE

CAS No.:
17097-76-6
Catalog Number:
AG00AOH5
Molecular Formula:
C20H36CaN2O10
Molecular Weight:
504.5852
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
Product Description
Catalog Number:
AG00AOH5
Chemical Name:
CALCIUM D-(+)-4-(2,4-DIHYDROXY-3,3-DIMETHYLBUTYLAMIDO)BUTYRATE HEMIHYDRATE
CAS Number:
17097-76-6
Molecular Formula:
C20H36CaN2O10
Molecular Weight:
504.5852
MDL Number:
MFCD01941641
IUPAC Name:
calcium;4-[[(2R)-2,4-dihydroxy-3,3-dimethylbutanoyl]amino]butanoate
InChI:
InChI=1S/2C10H19NO5.Ca/c2*1-10(2,6-12)8(15)9(16)11-5-3-4-7(13)14;/h2*8,12,15H,3-6H2,1-2H3,(H,11,16)(H,13,14);/q;;+2/p-2/t2*8-;/m00./s1
InChI Key:
OVXZVDMCQPLHIY-QXGOIDDHSA-L
SMILES:
OCC([C@H](C(=O)NCCCC(=O)[O-])O)(C)C.OCC([C@H](C(=O)NCCCC(=O)[O-])O)(C)C.[Ca+2]
UNII:
LK8EOC1M6K
Properties
Complexity:
246  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
3  
Defined Atom Stereocenter Count:
2  
Defined Bond Stereocenter Count:
0
Exact Mass:
504.2g/mol
Formal Charge:
0
Heavy Atom Count:
33  
Hydrogen Bond Acceptor Count:
10  
Hydrogen Bond Donor Count:
6  
Isotope Atom Count:
0
Molecular Weight:
504.59g/mol
Monoisotopic Mass:
504.2g/mol
Rotatable Bond Count:
12  
Topological Polar Surface Area:
219A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
Literature
Title Journal
[Pantogam and pantogam active: qualitative and quantitative features of the interaction with neurotransmitter receptors in vitro]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20120101
[Preventive and cessation therapy of mental disorders in patients with the acute coronary syndrome]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20120101
[Efficacy and tolerability of pantogam activ in patients with partial epilepsy]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20110101
[Attention-deficit hyperactivity disorder: determination of the optimal medical treatment duration]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20110101
[Pharmacokinetics of hopantenic acid upon peroral administration]. Eksperimental'naia i klinicheskaia farmakologiia 20100801
[Pantogam in the treatment of patients with organic brain lesions of different genesis]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20100101
[Asthenic disorders in children]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20100101
[The role of combat stress in the development of chronic pain syndrom in veterans and its treatment by pantogam active]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20100101
[Efficacy of pantogam in the treatment of hyperkinetic disorders in children]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20100101
[Pantogam active in the complex treatment of dystonic hyperkineses]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20100101
[The use of pantogam in patients with moderate cognitive disorders of vascular genesis]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20090101
Chemical knockout of pantothenate kinase reveals the metabolic and genetic program responsible for hepatic coenzyme A homeostasis. Chemistry & biology 20070301
[Pantogam in daily psychiatric practice]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20070101
[Effects of nootropic agents on visual functions and lacrimal antioxidative activity in patients with primary open-angle glaucoma]. Vestnik oftalmologii 20060101
[Antihypoxant and antiamnesic effects of calcium ketopantoylaminobutyrate]. Eksperimental'naia i klinicheskaia farmakologiia 20050101
[Pantothenic acid]. Nihon rinsho. Japanese journal of clinical medicine 20041201
[Toxicological characterization of calcium ketopantoylaminobutyrate]. Eksperimental'naia i klinicheskaia farmakologiia 20040101
[Comparative investigation of calcium ketopantoylaminobutyrate and pantogam: tranquilizer activity]. Eksperimental'naia i klinicheskaia farmakologiia 20040101
[Effect of pantogam on visual function and hemodynamic of eyes in patients with primary open-angle glaucoma]. Vestnik oftalmologii 20020101
[Psychophysiological effects of combined administration of pantogam and potassium orotate in patients with neurotic disorders]. Eksperimental'naia i klinicheskaia farmakologiia 20010101
Intracranial self-stimulation and locomotor traces as indicators for evaluating the homopantothenic acid. The Japanese journal of psychiatry and neurology 19931201
Naftidrofuryl oxalate, nootropic effects on the scopolamine- and the basal forebrain lesion-induced amnesia in rats. Pharmacology, biochemistry, and behavior 19910801
Properties